A law that coaxed companies to lower the price of drugs came with a little-known consequence: smaller discounts for ...

The price reduction is being enabled by cutting ... a basal insulin that is biosimilar to and interchangeable with Lantus (insulin glargine) injection. Priced at $92 per five pack of KwikPens ...

Toujeo is the next generation, longer-acting version of Lantus (insulin glargine ... at a discount of 15-20 per cent to Sanofi's brand price. Biosimilars are expected in Western Europe shortly ...

Pharmaceutical giant Sanofi has capped the price of its insulin, becoming the last of ... per month price cap on Lantus for those with private insurance. Sanofi's changes follow in the footsteps ...

Telehealth platform GoodRx has become the latest company to offer people with diabetes access to insulin for $35 per month— regardless of whether they have insurance. GoodRx said in a statement ...